Deepali Gupta

1.2k total citations
44 papers, 821 citations indexed

About

Deepali Gupta is a scholar working on Endocrine and Autonomic Systems, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Deepali Gupta has authored 44 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrine and Autonomic Systems, 14 papers in Physiology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Deepali Gupta's work include Regulation of Appetite and Obesity (15 papers), Tryptophan and brain disorders (11 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). Deepali Gupta is often cited by papers focused on Regulation of Appetite and Obesity (15 papers), Tryptophan and brain disorders (11 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). Deepali Gupta collaborates with scholars based in India, United States and United Kingdom. Deepali Gupta's co-authors include Mahesh Radhakrishnan, Yeshwant Kurhe, Thangaraj Devadoss, Jeffrey M. Zigman, Kripa Shankar, Sherri Osborne‐Lawrence, Nathan P. Metzger, Salil Varshney, Bharath K. Mani and Radhakrishnan Mahesh and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Deepali Gupta

42 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepali Gupta India 20 252 244 175 166 152 44 821
Linnea R. Freeman United States 17 595 2.4× 263 1.1× 130 0.7× 138 0.8× 90 0.6× 23 1.3k
Victoria Cano Spain 18 493 2.0× 414 1.7× 72 0.4× 197 1.2× 80 0.5× 36 1.2k
John D. Douglass United States 10 348 1.4× 423 1.7× 71 0.4× 52 0.3× 76 0.5× 14 968
Véronique De Smedt‐Peyrusse France 13 234 0.9× 79 0.3× 112 0.6× 110 0.7× 143 0.9× 19 921
Juliane Zemdegs Brazil 12 249 1.0× 107 0.4× 86 0.5× 119 0.7× 54 0.4× 24 693
Faruk Erden Türkiye 19 297 1.2× 84 0.3× 186 1.1× 399 2.4× 195 1.3× 67 1.1k
Silvana‐Yanina Romero‐Zerbo Spain 21 202 0.8× 110 0.5× 56 0.3× 188 1.1× 83 0.5× 30 1.1k
Anne‐Laure Dinel France 12 222 0.9× 123 0.5× 226 1.3× 71 0.4× 192 1.3× 23 798
Shigeo Miyata Japan 17 170 0.7× 76 0.3× 155 0.9× 248 1.5× 112 0.7× 39 675
A.M. Aleisa United States 18 229 0.9× 112 0.5× 87 0.5× 381 2.3× 153 1.0× 29 882

Countries citing papers authored by Deepali Gupta

Since Specialization
Citations

This map shows the geographic impact of Deepali Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepali Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepali Gupta more than expected).

Fields of papers citing papers by Deepali Gupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepali Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepali Gupta. The network helps show where Deepali Gupta may publish in the future.

Co-authorship network of co-authors of Deepali Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Deepali Gupta. A scholar is included among the top collaborators of Deepali Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepali Gupta. Deepali Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Deepali, Kripa Shankar, Salil Varshney, et al.. (2024). Impact of Ghrelin on Islet Size in Nonpregnant and Pregnant Female Mice. Endocrinology. 165(6). 1 indexed citations
2.
Varshney, Salil, Kripa Shankar, Lindsey Anderson, et al.. (2024). The LEAP2 Response to Cancer-Related Anorexia-Cachexia Syndrome in Male Mice and Patients. Endocrinology. 165(11). 5 indexed citations
3.
Singh, Omprakash, Salil Varshney, Kripa Shankar, et al.. (2023). Ghrelin-responsive mediobasal hypothalamic neurons mediate exercise-associated food intake and exercise endurance. JCI Insight. 8(24). 2 indexed citations
4.
Shankar, Kripa, Deepali Gupta, Salil Varshney, et al.. (2021). Ghrelin cell–expressed insulin receptors mediate meal- and obesity-induced declines in plasma ghrelin. JCI Insight. 6(18). 12 indexed citations
5.
Shankar, Kripa, Nathan P. Metzger, Omprakash Singh, et al.. (2021). LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue. Molecular Metabolism. 53. 101327–101327. 60 indexed citations
6.
Gupta, Deepali, Sherri Osborne‐Lawrence, Angie L. Bookout, et al.. (2021). Disrupting the ghrelin-growth hormone axis limits ghrelin's orexigenic but not glucoregulatory actions. Molecular Metabolism. 53. 101258–101258. 27 indexed citations
7.
Gupta, Deepali, et al.. (2020). “A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes”. Molecular Metabolism. 46. 101128–101128. 35 indexed citations
8.
Gupta, Deepali, Jen-Chieh Chuang, Bharath K. Mani, et al.. (2019). β1-adrenergic receptors mediate plasma acyl-ghrelin elevation and depressive-like behavior induced by chronic psychosocial stress. Neuropsychopharmacology. 44(7). 1319–1327. 30 indexed citations
9.
Rodriguez, Juan A., Emily C. Bruggeman, Bharath K. Mani, et al.. (2018). Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse Model. Endocrinology. 159(12). 4006–4022. 21 indexed citations
10.
Gupta, Deepali, Mahesh Radhakrishnan, Thangaraj Devadoss, & Yeshwant Kurhe. (2015). Pharmacological evaluation of novel 5-HT 3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery. Journal of Pharmacy And Bioallied Sciences. 7(2). 103–103. 8 indexed citations
11.
Gupta, Deepali, Mahesh Radhakrishnan, & Yeshwant Kurhe. (2014). Effects of Adhatoda vasica leaf extract in depression co‑morbid with alloxan‑induced diabetes in mice. International Journal of Green Pharmacy. 8(2). 97. 4 indexed citations
12.
Kurhe, Yeshwant, Radhakrishnan Mahesh, Deepali Gupta, & Thangaraj Devadoss. (2014). Effect of (4a) a novel 5-HT 3 receptor antagonist on chronic unpredictable mild stress induced depressive-like behavior in mice: an approach using behavioral tests battery. Journal of Basic and Clinical Physiology and Pharmacology. 26(1). 25–33. 9 indexed citations
13.
Gupta, Deepali, Mahesh Radhakrishnan, & Yeshwant Kurhe. (2014). 5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: Modulation of hypothalamic–pituitary–adrenocortical and brain serotonergic system. Pharmacology Biochemistry and Behavior. 124. 129–136. 32 indexed citations
14.
Gupta, Deepali, Mahesh Radhakrishnan, & Yeshwant Kurhe. (2014). Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice. Metabolic Brain Disease. 29(3). 737–746. 50 indexed citations
15.
Gupta, Deepali, Yeshwant Kurhe, & Mahesh Radhakrishnan. (2014). Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system. Physiology & Behavior. 129. 73–78. 66 indexed citations
16.
Kurhe, Yeshwant, Radhakrishnan Mahesh, Deepali Gupta, & Thangaraj Devadoss. (2014). QCM-4, a serotonergic type 3 receptor modulator attenuates depression co-morbid with obesity in mice: An approach based on behavioral and biochemical investigations. European Journal of Pharmacology. 740. 611–618. 17 indexed citations
17.
Gupta, Deepali, Mahesh Radhakrishnan, Thangaraj Devadoss, & Yeshwant Kurhe. (2014). Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models. European Journal of Pharmacology. 735. 59–67. 23 indexed citations
18.
Gupta, Deepali, Mahesh Radhakrishnan, & Yeshwant Kurhe. (2014). Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: Possible implication of serotonergic system. European Journal of Pharmacology. 744. 59–66. 38 indexed citations
19.
Kurhe, Yeshwant, Mahesh Radhakrishnan, & Deepali Gupta. (2014). Ondansetron attenuates depression co-morbid with obesity in obese mice subjected to chronic unpredictable mild stress; an approach using behavioral battery tests. Metabolic Brain Disease. 29(3). 701–710. 23 indexed citations
20.
Kurhe, Yeshwant, Radhakrishnan Mahesh, Thangaraj Devadoss, & Deepali Gupta. (2014). Antidepressant-like effect of a novel 5-HT3 receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests. Journal of Pharmacology and Pharmacotherapeutics. 5(3). 197–202. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026